Bumrungrad Hospital Public Company Limited
BUGDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $25,718 | $25,376 | $20,721 | $12,460 |
| % Growth | 1.3% | 22.5% | 66.3% | – |
| Cost of Goods Sold | $12,503 | $12,895 | $11,099 | $7,731 |
| Gross Profit | $13,215 | $12,481 | $9,621 | $4,729 |
| % Margin | 51.4% | 49.2% | 46.4% | 38% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $3,443 | $3,495 | $3,212 | $2,937 |
| SG&A Expenses | $4,171 | $4,180 | $3,798 | $3,296 |
| Sales & Mktg Exp. | $728 | $685 | $586 | $358 |
| Other Operating Expenses | -$122 | -$199 | -$187 | -$144 |
| Operating Expenses | $4,049 | $3,981 | $3,611 | $3,152 |
| Operating Income | $9,165 | $8,500 | $6,007 | $1,519 |
| % Margin | 35.6% | 33.5% | 29% | 12.2% |
| Other Income/Exp. Net | $271 | $138 | $42 | -$63 |
| Pre-Tax Income | $9,436 | $8,638 | $6,049 | $1,456 |
| Tax Expense | $1,604 | $1,583 | $1,072 | $216 |
| Net Income | $7,775 | $7,006 | $4,938 | $1,216 |
| % Margin | 30.2% | 27.6% | 23.8% | 9.8% |
| EPS | 9.78 | 8.08 | 6.21 | 1.53 |
| % Growth | 21% | 30.1% | 305.9% | – |
| EPS Diluted | 8.96 | 8.08 | 5.69 | 1.4 |
| Weighted Avg Shares Out | 795 | 867 | 795 | 795 |
| Weighted Avg Shares Out Dil | 867 | 867 | 867 | 867 |
| Supplemental Information | – | – | – | – |
| Interest Income | $279 | $141 | $46 | $69 |
| Interest Expense | $8 | $2 | $4 | $120 |
| Depreciation & Amortization | $1,077 | $1,097 | $1,117 | $1,180 |
| EBITDA | $10,522 | $9,737 | $7,170 | $2,768 |
| % Margin | 40.9% | 38.4% | 34.6% | 22.2% |